All the Therapeutic System Drugs
Human Coagulation Factor VIII (rDNA). Octocog Alfa 250 IU, 500 IU, 1000 IU, 1500 IU, 2000 IU, 3000 IU. VIAL: 1 x 250, 500, and 1000 IU (+ 5 ml
solv. dev. for reconst.). Dosage must be
ajust. individ.
Tmt. and prophylax. of bleed. in pts. with
Haemophilia A.
C/I: Hypersens. to the active subst., to
any of the excip. or to mouse or hamster
prot.
Antihemophilic Factor VIII 220 - 1700 IU. INFUS: (Dry pwdr): 10 ml. See lit.
Hemophil. A (classical hemophil.) for
prevent and control of hemorrhag.
episodes. Not indicat. in von Willebrand’s
disease.
Blood Coagulant. Coagulation factor IX recombinant - Rfix 250, 500, 1000, 2000 IU. VIAL (lyophilized pwdr. for injec.): 1×
250 IU, 500 IU, 1000 IU, 2000 IU.
IV use only after reconst., dosage must
be adjust. individ. for each pt. See lit.
Control/prevent. of hemorrh. epis. in pts
with hemoph. B (cong. factor IX defic./
Christmas dis.), incl. control/prevent. of
bleed. in surg. settings, in prev. treat. pts /
prev. untreat. pts. Not indicat. for the tmt
of other factor defic. (e.g. factors II,VII,
and X), nor for the tmt of hemoph. A, pts
with inh. to factor VIII, nor for the revers.
of coumarin-ind. anticoagul., nor for the
tmt of bleed. due to low levels of liverdepend. coagul. factors.
C/I: Pts with manifest. life-threat.,
immed. hypersensitivity react., incl.
anaphylaxis, to the product/compon.,
incl. hamster protein.
Blood Coagulation Factor. Human Coagulation Factor II 200 – 480, Human Coagulation Factor VII 100 – 250, Human Coagulation Factor IX 200 – 310, Human Coagulation Factor X 220 – 600, Protein C 150 – 450, Protein S 120 – 380. VIAL: 1 + diluent. I.V. inject. Amount,
freq. as per individ. pt. basis. See lit.
Tmt., periop. prophylax. bleed. in
acquired defic. prothrombin complex
coagulat. factors, e.g., defic. due to tmt.
vit. K antagonists, or overdose of vit. K
antagonists, when rapid correct. of the
defic. required.
Blood Coagulation Factor. Human Coagulation Factor II 400 – 960, Human Coagulation Factor VII 200 – 500, Human Coagulation Factor IX 400 – 620, Human Coagulation Factor X 440 – 1200, Protein C 300 – 900, Protein S 240 – 760. VIAL: 1 + diluent. I.V. inject. Amount,
freq. as per individ. pt. basis. See lit.
Tmt., periop. prophylax. bleed. in
acquired defic. prothrombin complex
coagulat. factors, e.g., defic. due to tmt.
vit. K antagonists, or overdose of vit. K
antagonists, when rapid correct. of the
defic. required.
Human Coagulation Factor VIII 25, 50, 100 IU/ml. VIAL: 1 x 250 IU, 500 IU, 1,000 IU (+ 10 ml
solv. in prefill. syringe). Adjust dose and
durat. accord. to pts needs.
Prevent. and control bleed. in mod. or
severe Factor VIII defic., due to classic.
hemophil. A. Not effect. in control. bleed.
Von Willebrand’s dis.
C/I: Allergic. reacts. to constits.